TFF Pharmaceuticals, Inc.
TFFPNASDAQHealthcare
$0.07
$-0.10(-60.05%)
Market Cap$288798
P/E Ratio—
52W High$11.0
52W Low$0.061
TFF Pharmaceuticals, Inc. (TFFP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TFFP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.73M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.50M | $0.39M | $0.11M | $0.00M | $0.00M |
| Gross Profit | $0.23M | ($0.39M) | ($0.11M) | $0.00M | $0.00M |
| Gross Margin %(computed) | 31.53% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $11.56M | $18.50M | $21.30M | $10.68M | $8.82M |
| G&A Expenses | $10.57M | $13.80M | $10.57M | $8.01M | $3.17M |
| Total Operating Expenses | $22.13M | $31.80M | $31.79M | $18.69M | $11.99M |
| Operating Income | ($21.89M) | ($31.80M) | ($31.79M) | ($18.69M) | ($11.99M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.03M | $0.05M | $0.13M | $0.12M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($21.24M) | ($31.77M) | ($31.04M) | ($18.57M) | ($11.87M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($21.24M) | ($31.77M) | ($30.99M) | ($18.44M) | ($11.75M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-11.85 | $-26.49 | $-31.21 | $-22.57 | $-42.55 |
| Wtd Avg Shares | 1.79M | 1.20M | 0.99M | 0.82M | 0.28M |
| EBITDA | ($20.74M) | ($31.41M) | ($30.93M) | ($18.69M) | ($11.99M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more TFF Pharmaceuticals, Inc. data
About TFF Pharmaceuticals, Inc. (TFFP) Income Statement
TFF Pharmaceuticals, Inc. (TFFP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, TFFP reported revenue of $0.00B, gross profit of $0.00B (gross margin 31.53%), and net income of ($0.02B) — a net profit margin of -2894.68%.
Frequently asked questions
TFFP · 4 questionsTFF Pharmaceuticals, Inc. (TFFP) reported revenue of $0.00B for 2023, up —% year-over-year.
TFFP revenueTFFP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09